Compugroup Medical Shares Outstanding vs. Revenue

COP Stock  EUR 14.02  0.06  0.43%   
Taking into consideration Compugroup Medical's profitability measurements, Compugroup Medical SE may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Compugroup Medical's ability to earn profits and add value for shareholders.
For Compugroup Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Compugroup Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Compugroup Medical SE utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Compugroup Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Compugroup Medical SE over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Compugroup Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Compugroup Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compugroup Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Compugroup Medical Revenue vs. Shares Outstanding Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Compugroup Medical's current stock value. Our valuation model uses many indicators to compare Compugroup Medical value to that of its competitors to determine the firm's financial worth.
Compugroup Medical SE is number one stock in shares outstanding category among its peers. It also is the top company in revenue category among its peers totaling about  19.63  of Revenue per Shares Outstanding. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Compugroup Medical's earnings, one of the primary drivers of an investment's value.

Compugroup Revenue vs. Shares Outstanding

Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Compugroup Medical

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
52.23 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Compugroup Medical

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
1.03 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Compugroup Revenue vs Competition

Compugroup Medical SE is the top company in revenue category among its peers. Market size based on revenue of Health Information Services industry is currently estimated at about 50.43 Billion. Compugroup Medical holds roughly 1.03 Billion in revenue claiming about 2.03% of equities under Health Information Services industry.

Compugroup Medical Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Compugroup Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Compugroup Medical will eventually generate negative long term returns. The profitability progress is the general direction of Compugroup Medical's change in net profit over the period of time. It can combine multiple indicators of Compugroup Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. CompuGroup Medical Societas Europaea was founded in 1979 and is headquartered in Koblenz, Germany. COMPUGROUP MED operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 5000 people.

Compugroup Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Compugroup Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Compugroup Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Compugroup Medical's important profitability drivers and their relationship over time.

Use Compugroup Medical in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Compugroup Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compugroup Medical will appreciate offsetting losses from the drop in the long position's value.

Compugroup Medical Pair Trading

Compugroup Medical SE Pair Trading Analysis

The ability to find closely correlated positions to Compugroup Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Compugroup Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Compugroup Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Compugroup Medical SE to buy it.
The correlation of Compugroup Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Compugroup Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Compugroup Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Compugroup Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Compugroup Medical position

In addition to having Compugroup Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Business Services Thematic Idea Now

Business Services
Business Services Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Business Services theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Business Services Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Compugroup Stock

To fully project Compugroup Medical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Compugroup Medical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Compugroup Medical's income statement, its balance sheet, and the statement of cash flows.
Potential Compugroup Medical investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Compugroup Medical investors may work on each financial statement separately, they are all related. The changes in Compugroup Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Compugroup Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.